Live feed
Filing
SC 13G
SC 13G0001193125-21-103729·Daewoong Pharmaceutical Co., Ltd.
Schedule 13G ownership disclosure
Evolus Inc
Security class unavailable · CUSIP: 30052C107
Event date: 2021-03-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-103729
- Form type
- SC 13G
- Filer
- Daewoong Pharmaceutical Co., Ltd.
- CIK
- CIK 1854452
- Filed
- Apr 01, 2021
- Reporting period
- Mar 25, 2021
- Description
- Schedule 13G beneficial ownership